Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

136

Citations

37

References

2024

Year

Feng Wang, Ying Jin, Min Wang, Hui Luo, Weijia Fang, Yingnan Wang, Yan‐Xing Chen, Run-Jie Huang, Wen‐Long Guan, Jibin Li,

Nature Medicine

Hdac InhibitorRandomized Phase 2Mss/pmmr Colorectal CancerMedicinePharmacologyColorectal CancerPathologyImmune Checkpoint InhibitorOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1